FREDELITO TIU: Open Payments
NPI 1346240843 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,362 in 133 payments from 25 companies in 2025. Trend: 2023 $617 · 2024 $1,667 · 2025 $2,362
Food & beverage: $2,362
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 23 | $508 |
| Novo Nordisk Inc | 16 | $328 |
| GlaxoSmithKline, LLC. | 19 | $254 |
| ABBVIE INC. | 18 | $241 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $176 |
| PFIZER INC. | 15 | $166 |
| Merck Sharp & Dohme LLC | 3 | $64 |
| Phathom Pharmaceuticals, Inc. | 4 | $61 |
| Amgen Inc. | 4 | $60 |
| Astellas Pharma US Inc | 3 | $59 |
Products named: AIRSUPRA, Ozempic, Kerendia, VRAYLAR, BYETTA, SHINGRIX, TRELEGY ELLIPTA, NURTEC ODT.
Industry payments across AZ — which companies pay providers there.
